NeuroGenetic Pharmaceuticals (United States)

NeuroGenetic Pharmaceuticals (United States)

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024.

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

74%


Total
Publications

62


Total Open
Publications

46


Total
Citations

1.9K


Open Access
Percentage

74%


Total
Publications

62


Total Open
Publications

46


Total
Citations

1.9K

Website

download

Breakdown

18% 50% 6% 26%

Publisher Open

18%

Both

50%

Other Platform Open

6%

Closed

26%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

14

Hybrid 50%

21

No Guarantees 17%

7

Other Platform Open

Domain 94%

33

Institution 6%

2

Preprint 3%

1

Public 3%

1

Other Internet 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
33
Europe PMC
Domain
9
wustl.edu OAI-PMH Repository
Institution
1
Washington University School of Medicine - Digital Commons@Becker
Institution
1
University of California - eScholarship University of California
Institution
1
Semantic Scholar
Public
1
Research Square
Preprint
1
1 / 1

Data updated 13 February 2025

Share

Share

Share